Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

June 3, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • DNA-Tales
  • THE BRAIN’S REWARD SYSTEM: NEUROBIOLOGY OF DRUG ADDICTION

Drug to treat African trypanosomiasis (sleeping sickness) disease discovered

CRISPR To Track Cancer In The Cells

THE BRAIN’S REWARD SYSTEM: NEUROBIOLOGY OF DRUG ADDICTION
  • Biotechnopedia
  • DNA-Tales

THE BRAIN’S REWARD SYSTEM: NEUROBIOLOGY OF DRUG ADDICTION

bioxone February 8, 2021February 8, 2021

Shinjini Bandopadhyay, Amity University Kolkata

Addiction is defined as a chronic, relapsing disease of the brain. It is a biological process that alters the neurochemical pathways in the brain. Although addictions may be of varying types, the most frequently occurring and the most damaging ones include substance abuse (drugs, alcohol, tobacco).

Substance abuse physically affects the structure of the brain and exploits a mechanism known as the brain’s ‘reward system’ by manipulating it. 

THE BRAIN REWARD CENTRE:

The core reward system of the brain is a circuit linking the ventral tegmental area, nucleus accumbens, and ventral pallidum by the medial forebrain bundle. The nucleus accumbens is a cluster of neurons located underneath the cerebral cortex; it is an essential component of the mesolimbic pathway. This is a major route for the release of the neurotransmitter– Dopamine and is hence called a dopaminergic pathway.

The experience of pleasure is distinctly identified by the release of dopamine in the nucleus accumbens. The mesolimbic pathway gets stimulated during these naturally rewarding experiences (intrinsic rewards such as satisfying food, social interaction, sexual activity, etc.)

This region of the brain is crucial for inducing motivation to perform rewarding activities, and also modulates the rewarding effect (as is, in the case of addictive drugs). Our brain is programmed to repeat rewarding behaviors as a survival instinct and to allow and re-experience the feelings of pleasure. 

Since the reward circuit in the brain includes areas that regulate motivation and memory besides pleasure, addictive substances can stimulate this network and then overload it.

(Fig.1. Diagram depicting the brain reward center complex)

DRUGS & DOPAMINE:

Dopamine not only contributes to pleasure but also plays important role in learning and memory, which are two key factors necessary to transition from enjoying something to becoming addicted to it.

According to recent research, dopamine is believed to interact with a different neurotransmitter— Glutamate, to hijack the brain’s system of reward-related learning. This same system plays a role in sustaining life because it connects activities/behaviors required for human survival. Addictive drugs create a shortcut to the brain’s reward system by excessively flooding the nucleus accumbens with dopamine. 

The natural reward pathways may be overshadowed by the effects derived from exposure to artificial rewards (such as drugs) as the latter release more substantial amounts of ‘feel-good’ chemicals such as dopamine. Addictive drugs are capable of releasing 2-10 times the amount of dopamine and the process is faster. 

HOW DOES ONE GET ADDICTED? 

Repeated exposure to an addictive substance causes nerve cells in the nucleus accumbens as well as the prefrontal cortex to co-relate simply liking something with the ability of craving something. This urges one to seek the source of pleasure one was previously exposed to. The more one repeats such specific behavior, the more reinforced it becomes, which creates a feedback loop. After some time, physical changes eventually occur in the brain structure, which alters the reward pathway permanently. 

Dopamine signaling is involved in storing information about the environmental stimuli associated with different experiences that induce pleasure and/or euphoria. The hippocampus establishes this connection and retains these memories which are created as a part of the ‘learning process’. Whenever a person is surrounded by the same stimuli again, they are reminded of the relief and satisfaction previously experienced by the addictive behavior. This leads to the next step which is– Compulsion. It’s where the memory of the first exposure to a drug leads to compulsive searching for re-consumption. 

DEVELOPMENT OF DOPAMINE TOLERANCE:

For some addictive drugs (e.g. opiates),  tolerance to euphoric effects manifests with chronic usage. With the continued intake of the drug, progressively the brain develops an adaptation to the dopamine secreted.

Long-term drug usage affects the brain reward system and the neurotransmitter itself. The dopamine receptors begin to decrease gradually while they adjust to the excessive concentrations of dopamine in the brain. This decrease in dopamine leads to the impulsive behavior of increased self-administration of drugs to try and maintain the earlier dopamine levels. This is then mediated by the nucleus accumbens; the addicted person experiences a strong desire to take more of the substance, even if it no longer gives them equal pleasure or satisfaction, simply to obtain the same dopamine ‘high’ again. This is an attempt to override the adaptation of the brain known as tolerance. 

THE RELAPSE:

All addictive drugs directly or indirectly induce common actions within the brain, such as enhancing the dopaminergic reward synaptic function in the nucleus accumbens. Once this pathway gets activated, it can lead to permanent changes in the brain which make withdrawal difficult and recovery may become a life-long process. Relapse is a major characteristic of addiction and even after long periods of abstinence, certain stimuli might trigger a renewed and persistent craving for the addictive substance. 

RECOVERY:

From a neurobiological standpoint, significant progress is predicted in targeting the reward pathways of the brain to control the severity of the damage caused by addiction. Further understanding the mechanisms of signaling in the brain and the role of neurotransmitters (such as dopamine) may aid potential treatment approaches for faster, more effective recoveries from addiction. 

Also read:Drug to treat African trypanosomiasis (sleeping sickness) disease discovered

REFERENCES:

  1. Chen W, Nong Z, Li Y, Huang J, Chen C, & Huang L (2017). Role of dopamine signaling in drug addiction. Current Topics in Medicinal Chemistry, 17(21). DOI: https://doi.org/10.2174/1568026617666170504100642
  2. Gardner E L (2011). Addiction and brain reward and antireward pathways. Chronic Pain and Addiction, 30, 22–60. DOI: https://dx.doi.org/10.1159%2F000324065
  3. Urban N B L & Martinez D (2012). Neurobiology of addiction. Psychiatric Clinics of North America, 35(2), 521–541. DOI: https://doi.org/10.1016/j.psc.2012.03.011
  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP
  • AI Literacy in Early Childhood Education: Challenges and Opportunities

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X

Related

Tagged addiction Brain Circuit dopamine drugs glutamate neurotransmitter nucleus accumbens Pathway pleasure recovery relapse reward tolerance

One thought on “THE BRAIN’S REWARD SYSTEM: NEUROBIOLOGY OF DRUG ADDICTION”

  1. Pingback: CRISPR To Track Cancer In The Cells - BioXone

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • World

CRISPR To Track Cancer In The Cells

bioxone February 8, 2021

Thota Kanishka Rao, Amity University Kolkata Cancer is one of the most dangerous diseases causing the death of millions globally. 1 out of every 6 deaths, around 6,000 people each day. There is no single test that can precisely analyze malignancy. The total evaluation of a patient for the most part requires a thorough history […]

CRISPR

Related Post

  • Biotechnopedia
  • DNA-Tales

The mind in the midnight hour

BioTech Today June 22, 2021June 22, 2021

Priasha Dutta, Amity University Kolkata Stages of sleep: Various research studies have elucidated the various aspects of the mind in the midnight hour. While we sleep and have dreams, our brain is directly involved in regulating our sleep cycles and monitoring sleep and dream quality. Sleep has two stages: (i) REM (rapid eye movement) (ii) […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • Biotechnopedia

Asymptomatic patients of COVID-19: threat to the population?

bioxone September 18, 2020September 18, 2020

-Anwesha Chatterjee, Amity University Kolkata The novel coronavirus is spreading rapidly throughout the world. It is impossible to restrict the spread of the SARS-CoV-2.  A huge proportion of the population across the world got infected and showed the most common to mild to serious symptoms (fever, dry cough, respiratory problems, conjunctivitis, aches, pains, rashes, and many more) along with the high […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • Biotechnopedia
  • DNA-Tales

Nanoparticle mediated drug delivery – the way of the future

bioxone November 28, 2020November 28, 2020

Srishti Deb, Amity University, Kolkata Nanoparticle: Technobiology’s wireless messenger – With the advancement of science and modern technologies, a more promising technology of drug delivery to selective tissues is used. This is a more potent targeted delivery process of therapeutic agents, that significantly eliminates drug or drug carrier side effects. Drug design and drug delivery […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy